Therefore, anti-CD36 monoclonal antibody treatment reveals profound effects on inhibiting melanoma tumor growth in the recipient mice, accompanied by induction of Treg cell apoptosis, enhanced CD8+ T cell infiltration, and higher cytokine production in CD4+ and CD8+ TILs. The gene discussed is CD8A; the disease is melanoma.